Trial
NCT02612428
Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Vital Therapies, Inc.
Collaborators
—
Condition
Acute Alcoholic Hepatitis
Intervention
ELAD System
Why stopped
VTL-308 failed to meet its primary endpoint, all follow up studies were terminated
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-25